BioNanomatrix Raises $23.3M in Series B Round

The financing comes as the company moves toward commercializing its silicon chip-based instrument for single-molecule genome analysis.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories